Semaglutide for weight management: a real-world study
Part of Hormones & metabolism clinical trials.
This study looks at the experiences of people using injectable semaglutide for weight loss, as well as the doctors who prescribe it. It aims to understand how the treatment works in everyday life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You live in Australia, Germany, United Arab Emirates, or Spain.
- You have been prescribed and started using injectable semaglutide for weight management.
- You are not pregnant or planning to become pregnant in the next 6 months.
- You are not using semaglutide only for type 2 diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.
This study tests whether a medication called semaglutide (which helps with weight loss) can change the bacteria in your gut, which might play a role in weight regulation. By participating, you may receive a treatment that could help you lose weight while researchers learn more about how it works.
This study tests a weekly injection called semaglutide to see how well it helps people with obesity lose weight, compared to a similar approved medicine, Wegovy. It may be an option if you have struggled to lose weight in the past.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
This trial tests a medicine called semaglutide (often used for diabetes) to see if it helps people in Bangladesh who are overweight or obese lose weight. The study will check if the medicine is safe and effective for both people with and without type 2 diabetes.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.